Diaboherb Oral Liquid
Increased blood sugar level is one of the most common under-diagnosed problems, with millions of Indians unaware that they are suffering from it. Unfortunately India has ranked No. 1, in December 2006, in diabetic population by International Diabetic Federation.
103.50 115.00 10% OFF
Pack Size(1)
Potency(1)
Product Details
Product Name: Diaboherb Oral Liquid And Capsules
Product SKU:
Available packs size: Bottle of 180 ml and Strip of 10 X 10 Capsules
Increased blood sugar level is one of the most common under-diagnosed problems, with millions of Indians unaware that they are suffering from it. Unfortunately India has ranked No. 1, in December 2006, in diabetic population by International Diabetic Federation.
Composition & Action of individual ingredients:
| Bimba (Coccinia indica) | Profuse urination, weakness and exhaustion after urination, sugar in urine and great thirst |
| Gurmar (Gymnema sylvestre) | Sugar destroyer (glycosuria), diabetic carbuncle |
| Jambu beej (Eugenia heyneana) | Causes great degree of diminution and disappearance of sugar in urine |
| Ulatkambal (Abroma augusta) | Dryness of mouth, thirst for large quantities, pain in extremities |
| Ban sangli (Crataegus oxyacantha) | Solvent power upon calcareous deposits in arteries |
Diaboherb has been clinically tried by IC Bio Clinical Research Pvt. Ltd., Bangalore; where it was found that diaboherb is effective in treating Type II Diabetes patients with positive outcome on the quality of life like Polyuria, Polydipsia, Polyphagia and Myalgia
In-house Clinically proven:
An In-house clinical trial was conducted at Guru Nanak Medical Centre, Nehru Nagar, New Delhi, by a well known senior physician and member of the Delhi Diabetic Forum, Dr. M.H. Khan et al to ascertain the efficacy of Diaboherb in the treatment of Diabetes mellitus and its effectiveness as an anti-hyperglycaemic drug.
The trial was conducted in 47 patients including both male and female within the age group of 35 to 90 years, suffering from NIDDM. The dosage given was 1 teaspoonful 3 times daily.
3 categories A, B and C were considered for conducting clinical trial.
GROUP A- Average blood sugar levels: Fasting (F) 132mg% & postprandial (PP) 190mg%.
GROUP B- Average blood sugar levels: (F) 181mg% & (PP) 246mg%.
GROUP C- Average blood sugar levels: (F) 271mg% & (PP) 360mg%.
The study was conducted for 12 weeks with blood sugar levels monitored every two weeks. All patients were advised to control their diet and encouraged some exercise.
RESULT:
Duration: 12 weeks
 |
|
| Advantages: |
|
|
Dosage: One teaspoonful three times daily Contraindications: No known contraindications. Side effects: Nil |
